Martin Shkreli – skyrocketing prices of an anti-parasitic drug
This article is #12 of the 12 most popular posts on Skeptical Raptor during 2015. Stay tuned, I’ll be reposting the rest of them through New Year’s Day.
It is a story about Martin Shkreli and Turing Pharmaceutical skyrocketing the price of pyrimethamine. Of course, he just got arrested for securities fraud, so it’s clear that Shkreli’s character is precisely what we thought it was.
Over the weekend, my newsfeed on Twitter and Facebook exploded with outrage and indignation about a story that was published in AddictingInfo.org and other outlets regarding skyrocketing prices of an anti-parasitic drug – pyrimethamine (trade name Daraprim) – which is used to treat parasitic infections, like toxoplasmosis and malaria.
Pyrimethamine is frequently used in AIDS patients whose suppressed immune systems allow frequent parasitic infections like toxoplasmosis. As opposed to the AddictingInfo headline, stating that pyrimethamine is a “60 year old cancer drug,” there is no evidence that it was ever a “cancer drug.” It may have been used as such 60 years ago, but today it is not.
So let’s review some of the issues around this drug, and what are facts, and what are most certainly not. But one more thing, does this price increase really matter?
Read More »Martin Shkreli – skyrocketing prices of an anti-parasitic drug